Skip to main content

REVIEW article

Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1482186
This article is part of the Research Topic Drug Repurposing to Fight Resistant Fungal Species: Recent Developments as Novel Therapeutic Strategies View all 4 articles

Artificial Intelligence in Predicting Pathogenic Microorganisms' Antimicrobial Resistance: Challenges, Progress, and Prospects

Provisionally accepted
Yan Li Yan Li 1*Xiaoyan Cui Xiaoyan Cui 2Xiaoyan Yang Xiaoyan Yang 3Guangqia Liu Guangqia Liu 4Juan Zhang Juan Zhang 1*
  • 1 Department of Pharmacy, Jinan Fourth People's Hospital, Jinan, China
  • 2 Pharmacy Department,Jinan Huaiyin People's Hospital, Jinan, China
  • 3 Pharmacy Department,Pingyin County Traditional Chinese Medicine Hospital, Jinan, China
  • 4 Pharmacy Department, Jinan Licheng District Liubu Town Health Centre, Jinan, China

The final, formatted version of the article will be published soon.

    The issue of antimicrobial resistance (AMR) in pathogenic microorganisms has emerged as a global public health crisis, posing a significant threat to the modern healthcare system. The advent of Artificial Intelligence (AI) and Machine Learning (ML) technologies has brought about revolutionary changes in this field. These advanced computational methods are capable of processing and analyzing large-scale biomedical data, thereby uncovering complex patterns and mechanisms behind the development of resistance. AI technologies are increasingly applied to predict the resistance of pathogens to various antibiotics based on gene content and genomic composition. This article reviews the latest advancements in AI and ML for predicting antimicrobial resistance in pathogenic microorganisms. We begin with an overview of the biological foundations of microbial resistance and its epidemiological research. Subsequently, we highlight the main AI and ML models used in resistance prediction, including but not limited to Support Vector Machines, Random Forests, and Deep Learning networks. Furthermore, we explore the major challenges in the field, such as data availability, model interpretability, and cross-species resistance prediction. Finally, we discuss new perspectives and solutions for research into microbial resistance through algorithm optimization, dataset expansion, and interdisciplinary collaboration. With the continuous advancement of AI technology, we will have the most powerful weapon in the fight against pathogenic microbial resistance in the future.

    Keywords: antimicrobial resistance, artificial intelligence, machine learning, Drug target prediction, Pharmacology

    Received: 17 Aug 2024; Accepted: 07 Oct 2024.

    Copyright: © 2024 Li, Cui, Yang, Liu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yan Li, Department of Pharmacy, Jinan Fourth People's Hospital, Jinan, China
    Juan Zhang, Department of Pharmacy, Jinan Fourth People's Hospital, Jinan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.